相关实验视频

Updated: Jan 14, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

新兴生物标志物用于早期检测和预测肝脏疾病

Jyoti Yadav¹, Avijit Mazumder¹, Saumya Das¹

¹Department of Pharmacology, Noida Institute of Engineering and Technology (Pharmacy Institute) Knowledge Park II, Greater Noida, 201306, Uttar Pradesh, India.

Current pharmaceutical design

|October 20, 2025

概括

将传统的肝功能测试与微RNA和外体细胞等新型生物标志物的结合,可以提高早期疾病检测和肝脏疾病的个性化治疗策略. 这些先进的标记器提供了更高的准确性和非侵入性诊断潜力.

科学领域:

生物化学生物化学
分子生物学分子生物学
肝病学肝病学是一种肝病学.

背景情况:

肝脏疾病需要准确的诊断和监测工具.
传统的生物标志物在早期检测和特异性方面存在局限性.
新兴生物标志物为改善肝病管理提供了潜力.

研究的目的:

审查和评估肝病诊断,监测和治疗的传统和新兴生物标志物.
要突出生物标志物的作用,如肝酶,microRNAs和外体在患者的结果.
评估这些生物标志物在个性化医学中的潜力.

主要方法:

关于传统和新兴生物标志物的文献综述.
分析生物标志物,包括肝酶,微RNA,外体和纤维化相关蛋白质.
专注于肝脏疾病的诊断,监测和治疗应用.

主要成果:

传统的生物标志物 (ALT,AST,胆红素) 对于肝功能评估至关重要.
新兴的生物标志物 (microRNAs,外体,MMPs,TIMPs) 提高了早期检测和监测.
综合生物标志物方法提高了诊断准确性和个性化治疗.

结论:

整合传统和新型生物标志物可以改善肝脏疾病的早期检测,诊断和个性化治疗.
微RNA和外体提供敏感,特异性和非侵入性诊断选择.
对于新生物标志物的常规临床使用,需要进一步验证.

关键词:

这就是ALT ALT.这就是为什么APAPAPAPAP.在 AST AST AST 中.多元化产业计划 (MMPs) 是指多元化的产业计划.据报道,MIR-1222号机器人是一架飞机.这就是米R-34A.

更多相关视频

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...